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Background: Recently, there has been a strong emphasis on identifying an in vitro model for neurotoxicity
research that combines the biological relevance of primary neurons with the scalability, reproducibility and genetic
tractability of continuous cell lines. Derived neurons should be homotypic, exhibit neuron-specific gene expression
and morphology, form functioning synapses and consistently respond to neurotoxins in a fashion indistinguishable
from primary neurons. However, efficient methods to produce neuronal populations that are suitable alternatives to
primary neurons have not been available.
Methods: With the objective of developing a more facile, robust and efficient method to generate enriched
glutamatergic neuronal cultures, we evaluated the neurogenic capacity of three mouse embryonic stem cell (ESC)
lines (R1, C57BL/6 and D3) adapted to feeder-independent suspension culture. Neurogenesis and neuronal
maturation were characterized as a function of time in culture using immunological, genomic, morphological and
functional metrics. The functional responses of ESNs to neurotropic toxins with distinctly different targets and
mechanisms of toxicity, such as glutamate, α-latrotoxin (LTX), and botulinum neurotoxin (BoNT), were also
evaluated.
Results: Suspension-adapted ESCs expressed markers of pluripotency through at least 30 passages, and
differentiation produced 97×106 neural progenitor cells (NPCs) per 10-cm dish. Greater than 99% of embryonic
stem cell-derived neurons (ESNs) expressed neuron-specific markers by 96 h after plating and rapidly developed
complex axodendritic arbors and appropriate compartmentalization of neurotypic proteins. Expression profiling
demonstrated the presence of transcripts necessary for neuronal function and confirmed that ESN populations were
predominantly glutamatergic. Furthermore, ESNs were functionally receptive to all toxins with sensitivities and
responses consistent with primary neurons.
Conclusions: These findings demonstrate a cost-effective, scalable and flexible method to produce a highly
enriched glutamatergic neuron population. The functional characterization of pathophysiological responses to
neurotropic toxins and the compatibility with multi-well plating formats were used to demonstrate the suitability of
ESNs as a discovery platform for molecular mechanisms of action, moderate-throughput analytical approaches and
diagnostic screening. Furthermore, for the first time we demonstrate a cell-based model that is sensitive to all
seven BoNT serotypes with EC50 values comparable to those reported in primary neuron populations. These data
providing compelling evidence that ESNs offer a neuromimetic platform suitable for the evaluation of molecular
mechanisms of neurotoxicity.
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The use of live animals or primary neurons for neurotox-
icity research is complicated by technical, ethical and eco-
nomic considerations. An alternative strategy is the use of
a cultured cell line that can be induced to exhibit neuronal
characteristics. To date, the most common of these
“neurogenic” cell lines are human and mouse neuroblasto-
mas, which often exhibit poor sensitivity to neurotoxins,
are comprised of heterogeneous phenotypes and may not
form functioning synapses, making it questionable how ac-
curately they model neuronal mechanisms of pathogenesis
[1-4]. An effective cell-based model system for neurotoxin
research would combine the biological relevance of pri-
mary neurons with the flexibility of continuous cell lines.
Such a model would exhibit normal neurogenic progres-
sion, faithfully recapitulate the full range of interactions
between primary neurons and neurotoxins, be compatible
with modern cell and molecular techniques and facilitate
moderate-throughput screening applications [5].
Early efforts to differentiate ESCs into neurons produced
cells with morphological and functional characteristics
similar to primary neurons [6-10]. These cultures also con-
tained a high percentage of glial cells and multiple neuron
subtypes, which significantly detracted from their suitability
as a basic research tool or therapeutic screening platform.
Recently, a variation of the 4/4 method (so named because
it involves withdrawal of leukocyte inhibitory factor (LIF)
from ESC aggregates for 4 days followed by supplementa-
tion with retinoic acid (RA) for 4 d) was described with sig-
nificantly improved neuronal yield and purity [11,12].
Widespread application of this protocol was limited by sev-
eral factors: custom media formulations were required;
multiple manipulations were needed to isolate ESCs from
feeder cell populations; and neurons were not produced at
yields amenable to moderate-throughput screening.
Here we demonstrate that the robust production of
enriched glutamatergic neurons from suspension-cultured
mouse ESCs using a variant of the 4/4 method offers a fa-
cile neuron model that exhibits high sensitivity to a variety
of biological neurotoxins and replicates stages of neuro-
genesis observed in dissociated primary neuron cultures.
We developed a facile, cost-effective procedure that
enables the rapid production of large numbers of highly
enriched glutamatergic ESNs from continuous suspension
cultures of murine ESCs. Immunological, genomic, mor-
phological and functional evaluations suggest that ESN
maturation and behavior recapitulate those described in
primary neurons. We further demonstrate that ESNs ap-
propriately respond to different neurotropic toxins (glu-
tamate, α-latrotoxin [LTX], and BoNT/A, /B, /C, /D, /F
and /G) at doses similar to primary neurons.
These data provide compelling evidence that suspension
culture-derived ESNs comprise a novel cell model for
neurotoxicity research that combines the verisimilitude ofprimary neurons with the flexibility of continuous cell
lines. The identification of a robust, scalable and sensitive
neuron-based research platform amenable to genetic
modification and compatible with moderate-throughput
techniques should enable detailed biochemical and mo-
lecular approaches that are not feasible in neurogenic cells
or primary neurons. We anticipate this platform to exped-
ite the identification and validation of novel therapeutic
approaches to a variety of neurotoxins as well as the eluci-
dation of molecular aspects of pathogenesis following
intoxication.
Results
Suspension-adapted ESCs remain pluripotent and
mitotically active
ESCs are traditionally maintained on feeder cells in the
presence of LIF and fetal calf serum to preserve germline
competency [13]. To adapt ESC lines to feeder cell-free
suspension culture, R1, D3 and C57BL/6 ESCs that had
been co-cultured with mitotically inactivated mouse em-
bryonic fibroblasts were dissociated and cultivated in
bacterial dishes until suspended aggregates developed.
Mitotic rates of the suspension-adapted ESCs stabilized
by five passages (Figure 1A) and mean doubling times
were 18.7 ± 2.4 h, 19.2 ± 2.1 h and 23.8 ± 1.9 h over 30
passages (R1, D3 and C57BL/6, respectively). Expression
of the pluripotency marker Oct3/4 did not vary through
30 passages, whereas withdrawal of LIF resulted in a loss
of Oct3/4 immunoreactivity within 8 d (Figure 1B). The-
oretical estimates of cumulative yield over 25 passages
from a single dish were 1026 ESCs (Figure 1C).
Suspension-adapted ESCs were differentiated into neu-
rons using a modified 4/4 protocol, with increased RA
concentrations and incubation under rotary conditions in
low-attachment dishes (Figure 2) [6,11,14]. We initially
observed that differentiation under static conditions
resulted in large, agglomerated complexes by DIV 0
(Figure 3A). Hypothesizing that agglomeration might limit
recovery of NPCs at DIV 0, NPC yields were compared
between static differentiation conditions versus differenti-
ation on a rotary shaker at 45 RPM. Rotary conditions
eliminated agglomeration and increased average yield by
290% to 97 × 106 NPCs per 10-cm dish (Figure 3A-B).
No differences were observed in NPC yield between
5–30 passages in any ESC line. In one instance, an R1
culture maintained for 65 passages produced 87 × 106
NPCs, which underwent normal neuronal development,
indicating that extended periods in suspension culture
may not interfere with neurogenic competence.
Differentiated cells express transcriptional, morphological
and immunological markers of neurogenesis
Neuronal maturation was characterized between DIV 1–28
using the dendritic marker MAP2, the axonal marker
Figure 1 Suspension-adapted ESNs remain mitotically stable
and express markers of pluripotency. A. ESC yields during the
first five passages after transition to suspension culture. B. Summary
of flow cytometry data demonstrating no substantive change in
Oct3/4 expression in three different mESC lines across 25 passages
in suspension culture (n=6 for each ESC line). LIF indicates leukocyte
inhibitor factor. A, B. Error bars indicate standard deviation. C. Black,
actual yields for a representative R1 ESC culture between 5–30
passages after suspension adaptation. Theoretical yields of ESCs (red,
filled) and NPCs (red, not filled) over 25 passages are also presented.
Figure 2 Timeline from production of suspension-adapted ESCs
to neuronal maturation. LIF: leukocyte inhibitory factor. RA: retinoic
acid. The presence or absence of RA or LIF is marked by a + or –.
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Although MAP2 was uniformly present at DIV 1, MAP-tau
expression was not widely observed in the majority ofneurons until DIV 3. Axonal arborization increased exten-
sively between DIV 3–14, while dendritic extension oc-
curred predominantly after DIV 14 (Figure 4). Weak
synapsin puncta were widely dispersed along axons at DIV
7, primarily in the absence of proximal dendrites, but as of
DIV 14, synapsin-1 staining accumulated at axodendritic
interfaces. By DIV 21, an extensive “lawn” of neurites was
apparent, with robust axonal arborization and elongated
dendrites appearing in close proximity to single or fascicu-
lated axons (Figures 4–5). Greater than 99% of surviving
cells expressed neuron-specific markers at DIV 7, and less
than one GFAP+ glial cell was observed per mm2 at DIV 21
(averaged across 25 mm2). Glial cells that did survive were
most often observed at regions of high neuron density
(not shown), suggesting that a supportive microenviron-
ment (e.g., cell-cell contact) may be permissive for glial
persistence in the absence of serum.
A presumptive neuronal phenotype was further evalu-
ated by expression profiling at DIV 14. An average of
9,963 ± 42 nuclear mRNA transcripts were detected at a
single copy or higher (Additional file 1: Table S1), of
Figure 3 Rotary conditions increase NPC yield during
differentiation. A. Bright-field images of ESCs differentiated under
static (left) or rotary conditions (right; 45 rpm). Rotary conditions
produced spherical aggregates without agglomeration. B. Average
NPC yields for each cell line at DIV 0. Rotary culture of cell
aggregates improves neural progenitor cell recovery approximately
three-fold (P < .001, n=5).
Figure 4 Immunological characterization of neuron maturation. ESNs
the dendritic marker MAP2 (red), the axonal marker MAP-tau (green) and p
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FPKM) [15]. Overall, ESNs expressed a broad range of
neurotypic genes (Additional file 2: Table S2), and 28%
of the most abundant transcripts coded for neuron-
specific proteins (Figure 6A). Gene expression was
highly enriched for a neuronal phenotype and strongly
associated with neuron-specific canonical pathways and
functions (Figure 6B-D). ESNs expressed high levels of
glutamatergic markers (vGluT2; 100.8 FPKM), with low-
to-moderate levels of GABAergic markers (13.9 FPKM
and less) and virtually no markers (< 0.4 FPKM) of cho-
linergic, serotonergic, dopaminergic or motor neuron
differentiation. A variety of neurotransmitter receptors
were expressed, including those for glycine, GABA,
acetylcholine (muscarinic and nicotinic) and glutamate
(metabotropic and ionotropic). ESNs also expressed
transcripts essential for synaptic activity and electro-
chemical signal propagation, including subunits of the
neuronal N- and P/Q-type voltage-dependent Ca2+
channels (VDCCs), SNARE proteins, synaptic vesicle-
associated proteins, Na+/K+ pumps, and a large number
of voltage-gated Na+, K+ and Cl- channels (summarized
in Additional file 2: Table S2).Depolarizing stimuli evoke reversible Ca2+ uptake
The expression of gated ion channels and pumps im-
portant in maintaining and altering membrane polarity
suggested that application of depolarizing stimuli might
elicit Ca2+ uptake. We altered the plasma membrane po-
tential using indirect (elevated K+) and direct (threewere evaluated at indicated days after plating (DIV) for localization of
resynaptic marker synapsin 1 (white).
Figure 5 ESNs develop large, complex axodendritic arbors by DIV 21. The extent of neuronal network complexity and development was
imaged over approximately 9 cm2 at DIV 21 by wide-field fluorescent microscopy. Red, dendritic marker MAP2; green, axonal marker MAP-tau.
The apposition of mature dendritic and axon processes is demonstrated as co-localized staining (yellow).
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at 10 Hz) methods and found that both methods of
depolarization elicited reversible Ca2+ influxes (Figure 7).
The functional verification of Ca2+ uptake in response to
classical depolarizing stimuli confirms intracellular
recordings and neurotransmitter release assays [11,14],
and suggests that ESNs may be sensitive to neurotoxic
stimuli whose mechanism of action involves dysregula-
tion of electrochemical signal propagation.
ESNs are sensitive to glutamatergic excitotoxicity
Glutamatergic excitotoxicity has been attributed to the
pathologic internalization of Ca2+ through post-synaptic
NMDA receptors, compounded by activation of VDCCs in
response to excitatory post-synaptic currents (EPSCs) from
AMPA and KA receptors [18,19]. In primary neuron cul-
tures, neurotoxicity has been reported over a wide range of
glutamate (glu) doses and exposure durations [20-23]. ESNs
express transcripts for NMDA, KA and AMPA receptor
subunits and the NMDA-associated protein Grina at high
levels (Additional file 1: Table S1), suggesting that ESNs
may be functionally sensitive to glu treatment. Treatment
of ESNs with 200 μM glu resulted in acute levels of Ca2+
uptake similar to those caused by K+, whereas the inhibi-
tory neurotransmitter GABA or vehicle controls had no ef-
fect (Figure 8A-B). Glu treatment resulted in significant
time- (2–24 h, Figure 8C) and dose-dependent (3.125-200
μM; Figure 8D) toxicity, further confirmed by morpho-
logical evidence of neurite degeneration 24 h after a 200
μM treatment (Figure 8E). Co-administration of the GluR
antagonists APV and CNQX afforded complete protection
against toxicity after a 2 h exposure to 3.125 and 12.5 μM
glu, and 50% protection against 50 μM glu. These results
indicate that ESNs undergo a time- and dose-dependent
glu toxicity that is mediated by ionotropic GluRs.
Neuron viability and Ca2+ influx following exposure to
alpha-latrotoxin (LTX)
Unlike glu exposure, which induces EPSCs in post-
synaptic compartments, LTX forms Ca2+-permissive poresin the presynaptic membrane that result in fulminant
neurotransmitter release and activation of non-synaptic
Ca2+-sensitive intracellular pathways [24]. ESNs express
transcripts of known LTX receptors (PTPRS, neurexin
1–3 and latrophilin 1–3; Additional file 1: Table S1), and
LTX treatment of ESNs evokes unregulated Ca2+ influx,
followed by morphological and biochemical indicators of
neurotoxicity [25]. To better characterize LTX toxicity, we
evaluated dose-dependent relationships between LTX,
onset and magnitude of Ca2+ uptake and neuron cell
death. The EC50 for Ca
2+ uptake at 20 min was deter-
mined to be 174.9 pM (95% C.I. [68.5, 281.3]; Figure 9A),
with positive correlations between dose, onset and magni-
tude of Ca2+ uptake (Figure 9B). We also demonstrated a
strong correlation between LTX dose and inhibition of
metabolic activity after a 30 min exposure (Figure 9C).
These findings illustrate the compatibility of ESNs with
moderate-throughput screening approaches, confirm that
ESN sensitivity and response to LTX are similar to those
of primary neurons, and demonstrate that ESNs offer a
novel platform with which to screen for therapeutics that
prevent LTX toxicity using multi-well formats [26,27].
ESNs are a biologically relevant model of BoNT
intoxication
ESNs strongly express transcripts and protein for proteo-
lytic targets (SNAP25, VAMP-2 and syntaxin) of the seven
BoNT serotypes and known protein receptors for pre-
synaptic uptake (SV2 or synaptotagmin; Additional file 2:
Table S2) [28]). We have shown that ESNs are sensitive to
femtomolar concentrations of BoNT/A and /E [14]. To de-
termine whether ESNs are a suitable model for the
remaining serotypes, we evaluated cleavage of the target
SNARE proteins after a 24 h exposure to BoNTs /B, /C,
/D, /F and /G (Figure 10A and Additional file 3: Figure S1).
ESNs exhibited similar or improved sensitivities to all
BoNT serotypes tested compared to primary mouse spinal
cord or cerebellar granule cell neurons, and several orders
of magnitude improved sensitivity over neuroblastoma
cells (Table 1) [29]. BoNT/C is the only holotoxin that
Figure 6 Characterization of RNA-seq data. A. Quantification of the fifty most abundant transcripts expressed in DIV 14 ESNs (n = 5 cultures).
Neurotypic (red) and synaptic function (checked red) genes are indicated. Error bars indicate standard deviations. B. IPA analysis of over-
represented canonical pathways, indicating p-values and the number of mapped and identified transcripts identified within each pathway. C. IPA
analysis of over-represented gene functions, indicating number of mapped and identified transcripts associated with each function. D. Tissue-
specific gene enrichment from 7939 mapped and identified transcripts with FPKM > 3.0 using Ingenuity Pathway Analysis (IPA). Right: Tissue-
specific enrichment among the 3000 most abundant genes determined using DAVID [16,17]. nf, not found.
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that intoxication of ESNs with BoNT/C resulted in cleav-
age of SNAP-25 as well as syntaxin-1 with roughly equiva-
lent EC50 values.
BoNT holotoxin binds to pre-synaptic receptors and is
internalized via synaptic endocytosis. Following cell
entry, the proteolytically active light chain is released to
the synaptic compartment through pores formed by the
heavy chain in the endosome membrane [28]. BoNT up-
take and/or activation has been reported to be enhanced
following intoxication under depolarizing conditions
(presumably the consequence of an accelerated rate ofsynaptic endocytosis) [28]. We found that a 5 min in-
toxication of ESNs by BoNT/A in depolarizing media
increased SNAP-25 cleavage by five-fold after 24 h as
compared to two different basal media (Figure 10B).
Discussion
ESC lines remain mitotically active, pluripotent and
neurogenic following adaptation to feeder-independent
suspension culture
With the aim of developing a more facile, robust and effi-
cient method for the production of homogenous neuronal
cultures from mouse ESC lines, we evaluated the
Figure 7 Depolarization elicits reversible Ca2+ influx. Ca2+ uptake was evaluated following membrane depolarization by KEB (A, B) or three
cycles of electrical field stimulation (10 Hz, 30 sec) (C, D). Time-lapse imaging of Ca2+ uptake (A, C) under depolarizing conditions, measured using the
fluorescent reporter GCaMP3 (A; genetically encoded) or Fluo-4 (C). Solid black bars in A and C indicate the duration of treatment. Baseline and peak
fluorescent intensities are demonstrated by the increase in GCaMP3 (B) or Fluo-4 (D) fluorescence. Error bars indicate standard error (A, C).
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suspension culture and differentiated under rotary condi-
tions. Mitotic rates of suspension-adapted R1, D3 and
C57BL/6 ESC lines were stabilized by five passages, and all
ESC lines remained mitotically active and expressed the
pluripotency marker Oct3/4 in the absence of feeder cells.
Germline competence was not evaluated, so it is unclear
whether these culture conditions restrict non-neurogenic
developmental fates. Adaptation to suspension culture
streamlined and economized ESC culture and neuronal dif-
ferentiation by obviating the need for feeder cells and allow-
ing the initiation of neuronal differentiation directly from
suspension cultures every 48 h. Suspension-cultured ESCs
remained neurogenic, and differentiated neurons exhibited
a multitude of neurotypic characteristics when maintained
in relatively inexpensive, commercially available media. We
found that the simple addition of a rotary step during dif-
ferentiation significantly increased neuron yield to levels
sufficient for moderate-throughput screening techniques.
These improvements resulted in the generation of sufficient
NPCs from one 10-cm dish to plate 776 cm2 of tissue cul-
ture surface (25 × 96-well dishes) at 125,000 cells per cm2.
Morphological and immunological characterization of
neurogenesis
The neurotypic character of ESNs was confirmed using
morphology, transcriptional profiling, immunocyto-
chemistry and functional characterization. Temporal
changes in MAP2, MAP-tau and synapsin-1 expressionand localization demonstrated a characteristic progression
through the first 4 stages of neurogenesis, as described by
Dotti et al. (1988) in embryonic hippocampal neurons, cul-
minating in a dense axodendritic arbor with punctate
localization of synapsin-1 at axodendritic interfaces. As
soon as DIV 1, a majority of ESNs produced short MAP2+
processes that were indistinguishable from one another,
characteristic of development stage (DS) 2 neurons [31,32].
Between DIV 1–3 most ESNs underwent rapid extension
of minor neurites and increased expression of axonal
markers, characteristic of DS 3 (Figure 4). Axons then
underwent rapid extension and arborization (DIV 3–21),
accompanied by the onset of dendritic outgrowth and
synaptogenesis at DS 4 (DIV 7–14). The earliest appear-
ance of synapsin accumulation at axodendritic interfaces
appeared between DIV 7–14, consistent with previous
demonstrations of characteristic pre- and post-synaptic
architectures at DIV 12 [14].
It should be noted that the plating density is important
in producing a neuronal population with few contamin-
ating, non-neuronal cells. Not only does serum with-
drawal at DIV 0 initiate the final stages of neuronal
differentiation, but it also eliminates the β3-tubulin non-
expressing cells, which are likely to be glial cells [14].
Glia that survive beyond DIV 4 tend to be localized to
regions of high neuron density. Thus, if NPCs are plated
at high density, then increased numbers of glia survive
serum-starvation. If unchecked, they can proliferate and
eventually overwhelm the ESN culture. We have found
Figure 8 ESNs exposed to glutamate exhibit acute and chronic sequelae mediated by GluRs. A. Fluo-4 measurements of Ca2+ uptake
following the addition of glu (green), GABA (solid, black) or vehicle control (open, black; n ≥ 19 for all samples). K+ (red) was used as a positive
control. Error bars indicate standard error. B. Representative images of Ca2+ uptake in ESNs incubated with Fluo-4 and treated with 200 μM glu.
C. Glu toxicity (200 μM) in ESNs is time-dependent (n=6 for each condition). Data are expressed as fold change relative to control populations.
Error bars indicate standard deviation. D. Co-administration of ionotropic GluR antagonists APV and CNQX (A/C) blocks glutamate-induced neuron
death at 2 h. * indicates P < 0.05 between control and indicated condition. ^ indicates P < 0.05 between glutamate and glutamate plus A/C. (+)
and (−) indicate the presence or absence of glutamate or APV/CNQX, respectively. Data are expressed as fold change relative to 0 μM glutamate.
E. Neurite degeneration and varicosity formation 24 h after exposure to 200 μM glutamate.
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pressed without detectibly altering neuron viability or
function by addition of 5-Fluoro-deoxyuridine/uridine
(10 μM each) from DIV 8–12.
During synaptogenesis, presynaptic proteins are
bundled and transported along axons in mobileprecursors of presynaptic sites known as cytoplasmic
transport packets (CTPs) [33,34]. Because synapsin-1
has been identified as a component of CTPs, the abun-
dant distribution of weak synapsin-1 puncta along
axons in the absence of proximal MAP2+ processes at
DIV 7 may represent the presence of CTPs [35].
Figure 9 LTX treatment results in acute Ca2+ influx and loss of
metabolic activity. A. Intracellular Ca2+ levels correlate to LTX dose
at 20 min after exposure (n = 8). B. Longitudinal characterization of
Ca2+ uptake over a 20 min period after LTX addition (n = 8). A, B.
Dotted line indicates the EC50 (representing the dose of LTX that
resulted in 50% of the maximum fluorescence) of 174.9 pM. Error
bars indicate the standard error. C. Dose-dependent reduction in
ESN viability 30 min after LTX addition (n = 8). The data are
expressed as fold-change relative to 0 μM glutamate. Error bars
indicate standard deviations.
Figure 10 ESNs exhibit sensitive and specific responses to
BoNTs. A. Log:lin plot calculated from densitometric measurements
of SNARE cleavage after a 24 h exposure to 0–17,800 pM BoNT/B,
BoNT/C, BoNT/D, BoNT/F and BoNT/G (n ≥ 5 for all time points). B.
Fractional cleavage of SNAP-25 after exposing ESNs to 6.7 or 67 pM
BoNT/A under depolarizing (K+) or basal (BEB or NB+B27) conditions
(n = 5). Error bars indicate standard error.
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to undergo synaptic vesicle recycling in the absence of
post-synaptic partners [33,36], possibly accounting for
the observation that ESNs are highly sensitive to
BoNT/A at DIV 6, prior to the formation of established
synapses [14].Transcriptional characterization of neurogenesis
Expression profiling and gene enrichment analyses of
RNA isolated from DIV 14 ESNs were consistent with
immunocytological evidence of neuronal phenotype. ESNs
express a large set of neurotypic transcripts, including the
post-mitotic nuclear marker NeuN, and abundant tran-
scripts indicative of a vGluT2+/vGluT1- glutamatergic
neuron subtype, with a smaller fraction expressing
GABAergic genes. These findings corroborate previous
reports indicating that > 95% of ESNs are vGluT2+ and
release glutamate in Ca2+-dependent fashion under de-
polarizing stimuli [14]. Consistent with evidence of synap-
togenesis, transcripts of genes essential to synapse
formation and function are also abundant. For example,
SNAP-25, VAMP2 and syntaxin 1a/b are all expressed in
the top 2% of all transcripts, emphasizing the importance
of neurotransmitter release to neuronal function. ESNs
also express a large number of genes essential for
Table 1 Sensitivities of primary neurons, SH-SY5Y human neuroblastomas and ESN to the seven classical BoNT
serotypes








BoNT/A SNAP-25 0.4A 5562 0.80 0.74 0.86
10B
BoNT/B VAMP2 100B 41,650 22.50 12.91 39.30
BoNT/C SNAP-25 13A nr 14.24 9.68 20.93
Syntaxin-1 nr nr 7.51 3.06 18.42
BoNT/D VAMP2 nr 2560 3.09 2.49 3.83
BoNT/E SNAP-25 36A nr 66.73 52.12 85.44
43B
BoNT/F VAMP2 1350B >300,000 157.82 133.25 186.92
BoNT/G VAMP2 nr nr 689.76 615.90 772.48
Notes: Primary neurons’ values are compiled from two sources. Annotation by (A) represents 50% inhibition of neurotransmitter release in rat cerebellar neuron
cultures exposed to BoNTs for 24 h (a 90% correlation was shown between neurotransmitter release and SNARE integrity) [29], whereas annotation by (B)
represents cleavage of 50% of SNAP-25 protein in fetal mouse spinal cord cultures exposed to BoNT for 48 h [30]. SH-SY5Y neuroblastomas’ values indicate
inhibition of 50% of noradrenalin release in SH-SY5Y human neuroblastomas cells after 72 h incubation [2]. ESN values represent 50% cleavage of SNARE
proteins after a 24 h tonic intoxication. ESN EC50 values for BoNT/B, /C, /D, /F and /G are from this manuscript, while BoNT/A and /E are from McNutt et al.
(2011). nr, not reported.
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ical signal propagation, providing a mechanistic basis for
previous demonstrations of Ca2+-dependent, K+-evoked
glutamate release and tetrodotoxin-sensitive measure-
ments of action potentials at DIV 12 [11,14].
Functional characterization of ESN responses to neuron-
specific stimuli
A relevant neuron-based research platform must exhibit
functional responses and sensitivities to neurotropic stim-
uli that are consistent with primary neurons. We first
demonstrated that two classical methods of membrane
depolarization (elevated K+ and field stimulation) rapidly
induced reversible Ca2+ uptake, confirming that ESNs
functionally express a wide range of voltage-gated ion
channels. ESNs exposed to glutamate or LTX exhibited
acute Ca2+ influx followed by cell death at doses and time-
scales similar to those reported in primary neuron popula-
tions [20-23,37,38]. These data suggest that ESNs offer a
scalable and genetically tractable neuron-based model sys-
tem that is amenable to characterization of excitotoxic
mechanisms and novel identification of therapeutic tar-
gets. Furthermore, the ability to evaluate multiple metrics
of toxicity in multi-well formats will facilitate moderate-
throughput screening for antagonists of NMDA receptor
activity, antagonists of LTX pore formation/function or
small molecules that mitigate acute or chronic aspects of
excitotoxic progression.
Unlike the excitogenic neurotoxins, the BoNTs inhibit
neurotransmitter release by cleaving SNARE proteins
with exquisite sensitivity. Since intoxication by BoNT
holotoxins is highly specific and critically dependent onthe function of a large set of neuron-specific proteins
within the presynaptic compartment, the sensitivity of a
cell population is therefore a reflection of presynaptic
function [28]. In combination with previous work, we
have now shown that ESNs are sensitive to all seven
classical BoNT serotypes, with EC50 values that are simi-
lar to those of primary neuron cultures and several
orders of magnitude improved over neurogenic cell lines
(Table 1). To our knowledge, this is the first time that a
cell line has been shown to be responsive to all sero-
types, including the dual-specificity of serotype /C.
These data indicate that ESNs functionally express the
necessary receptors, co-factors and substrates for the in-
ternalization and activation of all of the BoNT serotypes,
and suggest that BoNT is trafficked and processed in a
fashion similar to primary neurons.
Although the general mode of action is understood for
each of these neurotoxins, efforts to precisely characterize
cellular mechanisms of action have been complicated by
the lack of a neuromimetic model system that is amenable
to modern molecular and biochemical techniques. For the
first time, we demonstrate a single model system that is
highly sensitive to these neurotoxins at physiologically
meaningful concentrations, providing compelling evidence
that ESNs are a biologically relevant, functional model for
neurotoxicity research. Given that no other neurogenic
model has demonstrated comparable sensitivity and neur-
onal homogeneity to the botulinum neurotoxins [14],
ESNs appear to be a novel and relevant model in which to
conduct basic research, evaluate therapeutic candidates,
determine potencies and diagnose the presence of multiple
BoNT serotypes.
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We demonstrate a variant of the 4/4 neuronal differenti-
ation process that results in high yields of enriched neu-
rons, which respond to a variety of neurotropic stimuli in a
sensitive and reproducible manner. The robust production
of a highly enriched population that exhibits morphological
and functional evidence of a neuronal phenotype resolves
problems that have hindered moderate-throughput drug
screening approaches based on primary neurons (reprodu-
cibility, yield and cost) and neurogenic cells (verisimilitude,
homogeneity and sensitivity). ESNs do not suffer from al-
lelic variability and are genetically tractable, allowing the in-
terrogation of the role of specific genes in neurogenesis.
Repeated production of large quantities of ESNs is relatively
simple and offers a highly reductionist model amenable to
basic investigations of developmental and functional ques-
tions. Unlike dissociated primary cultures derived from
neonatal or postnatal CNS tissues, ESN production does
not involve disruption of previously established neuronal
interactions. Neurogenesis is synchronized and neuron
populations are highly enriched, reducing intra- and inter-
experimental variability. We anticipate that the ability to re-
capitulate pathophysiological responses in a relatively
homogeneous, scalable and genetically tractable neuron
model system will facilitate new approaches to neurotox-
icity and neurogenesis research, including detailed investi-
gation into molecular mechanisms of action, “omics”-based
discovery and diagnostic screening.
Although more work is needed to characterize neuro-
genesis and neuron maturation, the apparent similarities
between ESNs and dissociated primary neuron cultures
suggest that ESNs may also serve as a model system to
explore mechanistic aspects of neuron development,
synaptogenesis, neurotransmission and plasticity. The
same features that make ESNs a productive model for
neurotoxicity make them attractive platforms for mech-
anistic exploration of neurogenic mechanisms.
Methods
Reagents
R1, D3 and C57BL/6 ESC lines were obtained from
ATCC [39-41]. Pure botulinum holotoxin serotypes /A
(2.5 × 108 LD50/mg), /B (1.1 × 10
8 LD50/mg), /C (3.5 × 10
7
LD50/mg), /D (0.9 × 10
8 LD50/mg), /F (0.2 × 10
8 LD50/mg)
and /G (1.2 × 107 LD50/mg) were obtained from Meta-
biologics (Madison, WI) at 1 mg/mL in Ca2+/Mg2+-free
phosphate buffered saline, pH 7.4 (PBS), and stored
at −30°C. In the case of BoNT/G, toxin was first acti-
vated by a 60 min incubation at 37°C in 0.05 M
sodium phosphate buffer (pH 6.5), 0.3 mg/mL TPCK-
treated trypsin (Sigma-Aldrich, St Louis, MO) and 10%
glycerol. Activated toxin was diluted 1:1 with soybean tryp-
sin inhibitor and stored at −30°C until use. α-Latrotoxin
(LTX; Sigma-Aldrich) was resuspended to 300 nMin H2O and stored at −20°C. Mono-sodium glutamate
(Sigma-Aldrich) and γ-aminobutyric acid (GABA;
Sigma-Aldrich) were resuspended to 20 mM in PBS and
stored at 4°C. Solutions were diluted to the indicated
concentrations in basal electrophysiologic buffer (BEB; 10
mM glucose, 1 mM MgCl2, 10 mM HEPES, 2 mM CaCl2,
3 mM KCl, 136 mM NaCl and 0.1% BSA, pH 7.4, 310 ± 10
mOsm; Sigma-Aldrich). R-2-amino-5-phosphonopentanoate
(AVP, 50 μM, Sigma) and 6-cyano-7-nitroquinoxaline-2,3-
dione (CNQX, 10 μM, Sigma) were prepared in BEB
and added 1 h prior to and concurrent with the
addition of glutamate. Fluo-4 (Life Technologies,
Carlsbad, CA) was prepared per the manufacturer’s
instructions. Neurons were maintained in BEB during
time-lapse imaging. High potassium electrophysiologic
buffer (KEB) was prepared similarly to BEB, except
with substitutions of 60 mM KCl and 79 mM NaCl.
Electrical field stimulation (1 msec, 100 mV pulses at
10 Hz) of neurons on 18-mm cover slips was applied
via a field stimulation perfusion chamber (PC-49FS;
Warner Instruments, Hamden, CT) with a Grass S88
stimulator (Grass Medical Instruments, Quincy, MA).
Suspension adaptation and continuous mESC culture
R1, D3 and C57BL/6 cell lines that had been previously
maintained in adherent culture with mouse embryonic
fibroblasts (MEFs) were thawed and maintained at 37°C at
5% CO2 in 90% relative humidity in 10-cm bacterial plates
in 10 mL ESM (Knockout DMEM supplemented with
100 uM β-mercaptoethanol, 15% ES qualified fetal calf
serum [ATCC], 0.1mM nonessential amino acids, 2.0 mM
L-glutamine and 5000 units/mL penicillin/streptomycin
[Life Technologies] and 1000 units/mL recombinant
mouse leukemia inhibitory factor [LIF; Chemicon Inter-
national, Temecula, CA]). Alternatively, ESCs were main-
tained in commercially prepared complete ESC medium
(Millipore, Billerica, MA). Cells were observed daily and
passaged once aggregates became clearly visible (typically
4–8 days). Cells that were adherent or failed to divide dur-
ing adaptation were discarded. Surviving aggregates were
trypsinized, and 1.5 × 106 cells were inoculated into a fresh
10-cm bacterial dish with 10 mL ESM. ESCs were subcul-
tured every 48 h. For passaging, aggregates were allowed
to settle by gravity, washed once with 0.5 mL PBS and dis-
sociated for 3 min at 37°C with 0.5 ml of TrypLE Express
(Life Technologies). Dissociation was terminated with 0.5
mL of ESM, cells were gently triturated and 1.5 × 106
mESCs were transferred to a fresh 10-cm dish.
Generation of GCaMP3-expressing ESCs
Suspension-adapted R1 ESCs were stably transfected
with a genetically encoded Ca2+ construct (GCaMP3)
driven by the synthetic CAG promoter (Addgene plas-
mid 22692, Cambridge, MA) [42]. Five μL Lipofectamine
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pared per manufacturer’s instructions (Invitrogen) in a
total volume of 100 μL DMEM and added to 100 μL of
1 × 106 ESCs/mL in DMEM for 10 min at 37°C. Suspen-
sions were transferred to 10 mL ESM in a bacterial dish
and returned to an incubator. Media was changed at 1 d
and G418 selection (250 μg/mL; Sigma-Aldrich) started
at 2 d. Transient transfection rates exceeded 40%, as
estimated from basal fluorescence levels at 2d. Media
was subsequently changed every 4 d until G418-resistant
ESC aggregates developed. Stably transfected ES cell
aggregates (20–50 per transfected population) were iso-
lated and cultured as above until differentiation.
Neuronal differentiation
A modified 4/4 protocol was employed to differentiate
ESCs into neural progenitor cells [11,14]. Following rou-
tine sub-passaging, 3.5 × 106 dissociated ESCs were
transferred to 25 mL of differentiation medium (ESM
modified with 10% ES qualified fetal calf serum and
without LIF) in a 10-cm ultra-low attachment culture
dish (Corning, Lowell, MA). Differentiating aggregates
were maintained on a rotary shaker at 45 rpm at 37°C,
5% CO2 and 90% relative humidity. Complete media
changes were conducted at 48 h intervals, with the
addition of 6 μM retinoic acid (Sigma-Aldrich) at 4 and
6 days after starting differentiation.
On DIV 0, aggregates were dissociated with TrypLE
Express for 5 min at 37°C. Trypsinization was halted by
adding 5 mL of 1% soybean trypsin inhibitor (Life Tech-
nologies), the aggregates were gently dissociated by trit-
urating with a 10 mL pipet, and the cell suspension was
filtered through a 40-μm cell strainer (Thermo Scien-
tific). Cells were pelleted for 5 min at 300 × g, washed in
N2 medium (Neurobasal-A medium with 1x N2 vita-
mins, 2 mM glutamine and antibiotics [Life Technolo-
gies]) and counted. Cells were plated at 125,000
(coverslips) or 150,000 cells/cm2 (dishes) in N2 medium.
Complete washes were conducted at 4 h and 24 h to re-
move residual serum, gliotrophic factors secreted by glial
cells and non-adherent cells, and at 48 h after plating
(DIV 2), N2 was replaced with B27 medium (Neuroba-
sal-A supplemented with antibiotics, 2 mM glutamine
and 1x B27 vitamins [Life Technologies]). Subsequently,
cells underwent full medium changes with B27 on DIV 4
and 8, and then 50% media changes with B27 every fifth
day. Glial cell elimination by serum-starvation starting at
DIV 0 resulted in the loss of roughly 30% of plated cells
between DIV 2–4 [14].
Tissue culture treated dishes ranging in size from
10 cm to 24-well plates were prepared by coating with
0.5 μg/mL poly-D-lysine (PDL, Sigma-Aldrich) for at
least 3 h, followed by two quick washes with sterile
ddH20 and storage in N2 at 37°C until plating.Coverslips (18 mm, Thermo Fisher Scientific, Waltham,
MA) were coated with 200–300 μL of 0.5 μg/mL PDL
for 24 h at 37°C followed by 5 μg/mL laminin (Sigma-
Aldrich) in Knockout DMEM for 3 h and transferred
coated-side up to 12-well dishes. All characterization of
differentiated neurons was conducted exclusively with
neurons derived from R1 ESCs between 5–30 passages.
Immunoblotting
ESN cultures were lysed with 250 μL denaturing cell ex-
traction buffer (Life Technologies) and clarified by cen-
trifugation through a Qiashredder (Qiagen, Valencia,
CA); total protein concentration was determined by
bicinchoninic acid (BCA) analysis (Thermo Scientific,
Rockford, IL). Fifteen micrograms of total protein was
separated on a 10% (BoNT/B, BoNT/D, BoNT/F or
BoNT/G) or 12% (BoNT/A or /C) Nupage gel (Life
Technologies) with MOPS running buffer. Gels were
transferred to PVDF and probed for SNARE proteins
with a mouse anti-SNAP-25 antibody (SMI81; Covance,
Gaithersburg, MD), a mouse anti-VAMP2 antibody
(Synaptic Systems, Gottingen, Germany), and a mouse
anti-Syntaxin-1 (Synaptic Systems) diluted 1:1000 in
TBS Superblock with 0.05% Tween-20 (TBST; Life
Technologies). Proteins were visualized with goat anti-
mouse Alexa-488 labeled antibodies diluted 1:2500 in
TBST and imaged with a Versadoc MP4000 (Bio-Rad,
Hercules, CA).
Time-lapse microscopy
Images were collected on a Zeiss LSM-700 confocal
microscope with a constant-temperature environmental
chamber. For Fluo-4 staining, ESNs on 18-mm cover-
slips were stained and loaded in a perfusion chamber as
previously described [25]. Zen 2009 (Carl Zeiss, Inc,
Oberkochen, Germany) was used to determine the mean
fluorescence intensity over a fixed area using Fluo-4 and
GCaMP3 as indicators for the presence of cytosolic Ca2+.
Ca2+ uptake was induced with the application of KEB or
LTX at indicated quantities or by field stimulation. To
elicit action potentials by field stimulation, electrical
current was applied through platinum wires located in the
microscope field of view, using 1 msec, 100 mV pulses.
Neurons were stimulated with 3 cycles of approximately
300 action potentials at 10 Hz, with a 10 sec rest. The
data were normalized to ΔF/F0 via the following
equation: y = (FΔmin − F0 min)/F0 min.
Plate reader based quantification of Ca2+ uptake
ESNs were plated in either 24- or 48-well dishes, stained
and mounted as previously described and maintained at
25°C [25]. Ca2+ uptake was induced with the application
of chemical stimulation at indicated concentrations.
Changes in fluorescence were monitored with a Synergy
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VT) with excitation of 490/10 nm and emission of 520/
10 nm. The data were normalized via the following
equation: y = (Fx − F0)/F0.
Immunocytochemistry
Coverslips were fixed with 4% paraformaldehyde for
15 min at room temperature and blocked and permea-
bilized for 10 min in PBS with 0.1% saponin and 3% bo-
vine serum albumin (BSA) (PBSS). Coverslips were
incubated for 1 h with anti-MAP-Tau and anti-MAP2 pri-
mary antibodies (Synaptic Systems, Gottingen, Germany)
diluted 1:1000 and 1:500, respectively, in PBSS, washed
three times with PBSS and incubated for 1 h with goat
anti-mouse or anti-rabbit Alexa-labeled secondaries (Invi-
trogen) diluted 1:500 in PBSS. Coverslips were washed
three times in PBSS and incubated for 1 h with anti-
synapsin 1-Oyster 650 primary antibody (Synaptic Sys-
tems) diluted 1:500 in PBSS. Coverslips were washed three
times in PBS and mounted with Prolong Gold DAPI
mounting media (Life Technologies). Images were col-
lected with a Zeiss LSM 700 confocal microscope or Zeiss
LSM 510 confocal microscope and analyzed with Zen
2009 or 2008, respectively.
Differential interference contrast (DIC)/bright field
microscopy
For evaluation of neuronal morphology, images were
collected on a Zeiss LSM 700 confocal microscope with
a constant temperature chamber and analyzed with
AxioVision LE release 4.8.1. For evaluation of aggregate
morphology, images were collected on a Zeiss AxioOb-
server.A1 epi-fluorescence microscope and analyzed
with AxioVision release 4.7.1.
Flow cytometry
mESCs were collected during routine subculture and
washed twice with PBS. Cells were fixed with parafor-
maldehyde, permeabilized and stained for Oct3/4 ex-
pression or with appropriate isotype controls using the
Human and Mouse Pluripotent Stem Cell Analysis Kit
(BD Biosciences, San Jose, CA). Stained cells were ana-
lyzed on a BD FACSAria II flow cytometer using
manufacturer-specified laser excitation wavelength and
emission filter sets. At least 10,000 gated events were
recorded and analyzed for each sample. Density plots
and fluorescence intensity histograms were generated
using FCS Express, and experimental samples were nor-
malizing to isotype controls.
Quantitation of ESN viability
ESNs were plated in either 24- or 48-well dishes and
maintained under indicated conditions. PrestoBlue (Invi-
trogen) was added per manufacturer’s protocols in freshNBA-B27, and ESNs were incubated for 45 min at 37°C.
Metabolic conversion of PrestoBlue was measured using
an excitation of 535 nm and emission of 595 nm with a
Synergy MX plate reader.
Expression profiling
RNA was harvested from 10-cm dishes of DIV 14 ESNs
(n=5) using RNeasy mini kit (Qiagen) and submitted to
Expression Analysis (Durham, NC) for RNA sequencing
(2 × 25 paired-end, on an Illumina HiSeq 2000 [San
Diego, CA]). Transcriptome data were aligned using
UCSC’s mouse knowngene transcriptome with Tophat.
Unaligned reads were then aligned to the genome using
BWA and merged with the Tophat alignments [43]. Tran-
script abundances were determined using RSEM v1.1.13
and normalized by calculating the fragments of exon per
million mapped reads (FPKM) [44,45]. Normalized data
were analyzed for enrichment of canonical pathways, gene
function and tissue expression by Ingenuity Pathway Ana-
lysis (Ingenuity Systems, Redwood City, California). The
most abundant 3000 transcripts were also analyzed for
gene functional classification and tissue enrichment using
Database for Annotation, Visualization, and Integrated
Discovery (DAVID) [16,17].
Statistics
BoNT and LTX EC50 values were calculated using a
four -parameter sigma model from average dose response
values determined from densitometry of western blot
images and presented as median values with 95% confi-
dence intervals (C.I.). Multiple comparisons were per-
formed using one-way analysis of variance (ANOVA) to
determine significance. Differences among means were
determined and calculated with the Student's t-test.
* indicates a P < 0.05. ** indicates a P < 0.01. *** indicates
a P < 0.001. IPA and DAVID generated the p-values
adjusted for multiple hypotheses.
Additional files
Additional file 1: Table S1. Normalized transcript expression for DIV 14
ESNs. Gene names, average FPKMs, standard deviations and coefficient of
variations for DIV 14 ESN samples (n=5).
Additional file 2: Table S2. Summary of neurotypic gene expression in
DIV 14 ESNs. Representative transcripts involved in neuron function,
neurogenesis or neurotoxin function are included. Highlighted sequences
represent abundant transcripts, defined as an average reads per kilobase
of exon per million mapped sequences (FPKM) exceeding 30.
Additional file 3: Figure S1. Representative immunoblots
demonstrating dose-dependent proteolysis of target specific SNARE
proteins 24 h after exposure.
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